AstraZeneca sees 2022 growth as dividend increases

AstraZeneca sees 2022 growth as dividend increases

February 11, 2022: -On Thursday, AstraZeneca forecast higher 2022 sales and raised its annualized dividend after the drugmaker posted better-than-expected fourth-quarter profit as it gets a lift from its Covid-19 antibody treatment and cancer drugs.

But the London-listed company warned that gross profit margins from coronavirus products were expected to be less than the company average for this year. In contrast, sales for Covid-19 products were expected to decline by a percentage in the low-to-mid 20s.

AstraZeneca has said that low-income nations would continue to receive its vaccine on a no-profit basis after it started making a modest profit on the shot set up a separate unit to focus on its coronavirus efforts and different respiratory infections.

“AstraZeneca continued on its strong growth trajectory in 2021, five of our medicines crossing a new blockbuster threshold,” Chief Executive Pascal Soriot said.

The Anglo-Swedish drugmaker expected 2022 revenue to increase by a percentage in the high teens, with core earnings growing by a portion in the mid-to-high 20s. In 2021, overall sales jumped 38% to $37.42 billion at constant currency rates.

Analysts estimate $6.68 per share and sales of $42.73 billion, according to Refinitiv IBES data.

The company, seen by analysts as one of the fastest-growing significant drugmakers mainly thanks to new cancer therapies, also said it would top up its annualized dividend by $0.10 to $2.90, the first year-on-year increase in a decade.

About Us

We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.

Recent Posts

Transforming the delivery of Professional Services Worldwide |  Zain Ali

Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.

The must have Travel App after lockdown | Tiff Burns

Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.

The Technology Expert | Tarcisio Vergani

Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.

Perpetua Investment Group A Man of Action | Mehdi El Jazouli

Manufacturers often struggle with generating accurate and timely quotes, delaying customer responses and risking profitability. Traditional quoting processes can take days or even weeks, while customers expect responses within 24 hours. Micro Estimating Systems addresses these challenges with advanced software that allows users to generate highly accurate quotes in minutes. By integrating with shop-specific data and automating feature recognition, their solutions ensure precision and speed, empowering manufacturers to make informed decisions and enhance their operational efficiency.

AstraZeneca sees 2022 growth as dividend increases